Eyeing biodefense angle, NATO fund backs sequencing company Portal: Finance Report

The first disclosed biotech investment from the NATO Innovation Fund went to Portal Biotech, a London-based life sciences tools company that could play a part in detecting biological threats.

NATO Innovation Fund, an investment vehicle that raised a €1 billion fund in 2023 that now includes contributions from 24 NATO countries, co-led the $35 million series A round for Portal Biotech Ltd. with Berlin-based Earlybird Venture Capital. The start-up is developing benchtop instruments capable of full-length single-molecule protein sequencing...